Broadly neutralizing antibodies and monoclonal V2 antibodies derived from RV305 inhibit capture and replication of HIV-1

被引：0

作者：

Kim, Jiae ^{[1
,2
]}

Villar, Zuzana ^{[1
,2
]}

Jobe, Ousman ^{[1
,2
]}

Rerks-Ngarm, Supachai ^{[3
]}

Pitisuttithum, Punnee ^{[4
]}

Nitayaphan, Sorachai ^{[5
]}

O'Connell, Robert J. ^{[6
]}

Ake, Julie A. ^{[7
]}

Vasan, Sandhya ^{[1
]}

Rao, Venigalla B. ^{[8
]}

Rao, Mangala ^{[2
]}

机构：

[1] US Mil HIV Res Program, Henry M Jackson Fdn Advancement Mil Med, 6720A Rockledge Dr, Bethesda, MD 20817 USA

[2] US Mil HIV Res Program, Walter Reed Army Inst Res, Ctr Infect Dis Res, Lab Adjuvant & Antigen Res, Silver Spring, MD 20910 USA

[3] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand

[4] Mahidol Univ, Fac Trop Med, Vaccine Trial Ctr, Salaya, Thailand

[5] Armed Forces Res Inst Med Sci, Bangkok, Thailand

[6] United States Army Med Component, Armed Forces Res Inst Med Sci, Bangkok, Thailand

[7] US Mil HIV Res Program, Walter Reed Army Inst Res, Ctr Infect Dis Res, Silver Spring, MD 20910 USA

[8] Catholic Univ Amer, Bacteriophage Med Res Ctr, Dept Biol, 620 Michigan Ave,NE, Washington, DC 20064 USA

来源：

VIROLOGY | 2024年 / 597卷

关键词：

Virus capture; Broadly neutralizing antibodies; V2; region; Monoclonal antibodies; Primary virus; HIV-1; vaccine; RV144; RV305; PBMCs; qRT-PCR; EFFICACY; INFECTION; AIDSVAX; REVEAL; BINDS; ALVAC;

D O I：

10.1016/j.virol.2024.110158

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

An important approach to stopping the AIDS epidemic is the development of a vaccine that elicits antibodies that block virus capture, the initial interactions of HIV-1 with the target cells, and replication. We utilized a previously developed qRT-PCR-based assay to examine the effects of broadly neutralizing antibodies (bNAbs), plasma from vaccine trials, and monoclonal antibodies (mAbs) on virus capture and replication. A panel of bNAbs inhibited primary HIV-1 replication in PBMCs but not virus capture. Plasma from RV144 and RV305 trial vaccinees demonstrated inhibition of virus capture with the HIV-1 subtype prevalent in Thailand. Several RV305 derived V2-specific mAbs inhibited virus replication. One of these RV305 derived V2-specific mAbs inhibited both virus capture and replication, demonstrating that it is possible to elicit antibodies by vaccination that inhibit virus capture and replication. Induction of a combination of such antibodies may be the key to protection from HIV-1 acquisition.

引用

页数：8

共 50 条

[21] Use of broadly neutralizing antibodies for HIV-1 prevention
Pegu, Amarendra
Hessell, Ann J.
Mascola, John R.
Haigwood, Nancy L.
IMMUNOLOGICAL REVIEWS, 2017, 275 (01) : 296 - 312
[22] Broadly neutralizing antibodies for HIV-1 prevention and therapy
Julg, Boris
Barouch, Dan
SEMINARS IN IMMUNOLOGY, 2021, 51
[23] V4 region of the HIV-1 envelope gene mediates immune escape and may not promote the development of broadly neutralizing antibodies
Ji, Yangtao
Han, Xiaoxu
Tian, Wen
Gao, Yang
Jin, Su
Zhang, Linqi
Shang, Hong
VACCINE, 2018, 36 (50) : 7700 - 7707
[24] Broadly Neutralizing Antibodies and their Significance for HIV-1 Vaccines
Gonzalez, Nuria
Alvarez, Amparo
Alcami, Jose
CURRENT HIV RESEARCH, 2010, 8 (08) : 602 - 612
[25] Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, Xueling
Yang, Zhi-Yong
Li, Yuxing
Hogerkorp, Carl-Magnus
Schief, William R.
Seaman, Michael S.
Zhou, Tongqing
Schmidt, Stephen D.
Wu, Lan
Xu, Ling
Longo, Nancy S.
McKee, Krisha
O'Dell, Sijy
Louder, Mark K.
Wycuff, Diane L.
Feng, Yu
Nason, Martha
Doria-Rose, Nicole
Connors, Mark
Kwong, Peter D.
Roederer, Mario
Wyatt, Richard T.
Nabel, Gary J.
Mascola, John R.
SCIENCE, 2010, 329 (5993) : 856 - 861
[26] Lessons from babies: inducing HIV-1 broadly neutralizing antibodies
Tomaras, Georgia D.
Haynes, Barton F.
NATURE MEDICINE, 2014, 20 (06) : 583 - 585
[27] A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site
Li, Liuzhe
Wang, Xiao-Hong
Williams, Constance
Volsky, Barbara
Steczko, Olivia
Seaman, Michael S.
Luthra, Kalpana
Nyambi, Phillipe
Nadas, Arthur
Giudicelli, Veronique
Lefranc, Marie-Paule
Zolla-Pazner, Susan
Gorny, Miroslaw K.
MOLECULAR IMMUNOLOGY, 2015, 66 (02) : 364 - 374
[28] Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination
A. N. Vzorov
L. V. Uryvaev
Molecular Biology, 2017, 51 : 819 - 829
[29] Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Qian Wang
Linqi Zhang
Frontiers of Medicine, 2020, 14 : 30 - 42
[30] HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Dufloo, Jeremy
Bruel, Timothee
Schwartz, Olivier
RETROVIROLOGY, 2018, 15

← 1 2 3 4 5 →